Microbot Medical Inc.

Historical 13F Holders

Reported Value, Excluding Options

Total Filings

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 59503A204 since 12/18/2024, newest first.

Filer	% of Class	Shares	Form	Filed
Intracoastal Capital LLC 13G	8.2%	6,002,185	13G	1/23/2026 Event 1/15/2026
Mitchell P. Kopin	8.2%	6,002,185
Daniel B. Asher	8.2%	6,002,185
Intracoastal Capital LLC	8.2%	6,002,185
Intracoastal Capital LLC 13G/A Amendment 3	0%	0	13G/A Amendment 3	11/7/2025 Event 9/30/2025
Mitchell P. Kopin	0%	0
Daniel B. Asher	0%	0
Intracoastal Capital LLC	0%	0
Vanguard Group Inc 13G/A Amendment 1	4.5%	2,343,561	13G/A Amendment 1	10/31/2025 Event 9/30/2025
Intracoastal Capital LLC 13G/A Amendment 2	10.0%	4,200,951	13G/A Amendment 2	8/12/2025 Event 6/30/2025
Mitchell P. Kopin	10.0%	4,200,951
Daniel B. Asher	10.0%	4,200,951
Intracoastal Capital LLC	10.0%	4,200,951
Vanguard Group Inc 13G	5.6%	2,050,638	13G	7/29/2025 Event 6/30/2025
CVI Investments, Inc. 13G/A Amendment 1	4.9%	1,824,807	13G/A Amendment 1	5/12/2025 Event 3/31/2025
CVI Investments, Inc.	4.9%	1,824,807
Heights Capital Management, Inc.	4.9%	1,824,807
Intracoastal Capital LLC 13G/A Amendment 1	6.3%	2,349,488	13G/A Amendment 1	5/9/2025 Event 3/31/2025
Mitchell P. Kopin	6.3%	2,349,488
Daniel B. Asher	6.3%	2,349,488
Intracoastal Capital LLC	6.3%	2,349,488
CVI Investments, Inc. 13G	6.1%	1,257,143	13G	1/13/2025 Event 1/6/2025
CVI Investments, Inc.	6.1%	1,257,143
Heights Capital Management, Inc.	6.1%	1,257,143
Intracoastal Capital LLC 13G	8.8%	2,672,084	13G	1/10/2025 Event 1/6/2025
Mitchell P. Kopin	8.8%	2,672,084
Daniel B. Asher	8.8%	2,672,084
Intracoastal Capital LLC	8.8%	2,672,084

Period	Filings	Shares, Excl. Options	Value, Excl. Options	Options Value
2026 Q3	5	118 k	$141 k	$0
2026 Q2	75	11.3 M	$22.1 M	$654 k
2026 Q1	86	14.2 M	$34.3 M	$1.02 M
2025 Q4	77	11.4 M	$22.8 M	$956 k
2025 Q3	76	9.85 M	$30.1 M	$2.18 M
2025 Q2	57	4.39 M	$11.1 M	$1.15 M
2025 Q1	51	2.16 M	$3.26 M	$262 k
2024 Q4	40	1.10 M	$1.24 M	$0
2024 Q3	27	1.04 M	$933 k	$0
2024 Q2	39	1.09 M	$1.11 M	$0
2024 Q1	37	1.45 M	$1.77 M	$0
2023 Q4	44	1.55 M	$2.55 M	$26.7 k
2023 Q3	35	1.00 M	$1.40 M	$16.4 k
2023 Q2	32	1.24 M	$3.36 M	$7.00 k
2023 Q1	30	1.42 M	$2.94 M	$0
2022 Q4	26	1.52 M	$4.56 M	$0
2022 Q3	24	803 k	$3.84 M	$0
2022 Q2	26	703 k	$3.61 M	$0
2022 Q1	29	741 k	$4.65 M	$0
2021 Q4	29	813 k	$6.10 M	$0
2021 Q3	26	778 k	$5.47 M	$0
2021 Q2	31	755 k	$6.00 M	$0
2021 Q1	28	807 k	$6.86 M	$0
2020 Q4	28	766 k	$5.28 M	$0
2020 Q3	27	773 k	$5.93 M	$0
2020 Q2	25	683 k	$4.72 M	$0
2020 Q1	32	703 k	$3.90 M	$0
2019 Q4	30	685 k	$6.97 M	$0
2019 Q3	32	614 k	$3.25 M	$0
2019 Q2	31	636 k	$3.27 M	$0
2019 Q1	31	602 k	$4.66 M	$0
2018 Q4	34	245 k	$419 k	$0
2018 Q3	30	123 k	$912 k	$0